Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000255320 | SCV000321889 | pathogenic | not provided | 2015-12-02 | criteria provided, single submitter | clinical testing | The c.1464delG pathogenic variant in the MEN1 gene has not been reported, to our knowledge, in the literature as a pathogenic variant nor as a benign variant. The deletion causes a frameshift starting with codon Lysine 488, changes this amino acid to an Asparagine residue and creates a premature Stop codon at position 71 of the new reading frame, denoted p.Lys488AsnfsX71. This variant is predicted to result in premature protein truncation. In addition, c.1464delG was not observed in approximately 5,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. |
Ambry Genetics | RCV000490970 | SCV000579712 | pathogenic | Hereditary cancer-predisposing syndrome | 2015-03-20 | criteria provided, single submitter | clinical testing | The c.1464delG pathogenic mutation, located in coding exon 9 of the MEN1 gene, results from a deletion of one nucleotide at position 1464, causing a translational frameshift with a predicted alternate stop codon. Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). |